The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
SARS-CoV-2 infection (COVID-19) results in local and systemic activation of inflammation and coagulation. In this review article, we will discuss the potential role of coagulation factor Xa (FXa) in the pathophysiology of COVID-19. FXa, a serine protease, has been shown to play a role in the cleavag...
Main Authors: | Galit H. Frydman, Michael B. Streiff, Jean M. Connors, Gregory Piazza |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2020-10-01
|
Series: | TH Open |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1718415 |
Similar Items
-
The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
by: Frydman, Galit H., et al.
Published: (2021) -
Electrochemical Monitoring in Anticoagulation Therapy
by: Ashwin K. V. Mruthunjaya, et al.
Published: (2024-03-01) -
Calibration and validation of the rabbit model of electrolytic‐mediated arterial thrombosis against the standard‐of‐care anticoagulant apixaban
by: Pancras C. Wong, et al.
Published: (2022-06-01) -
Viscoelastometry for detecting oral anticoagulants
by: Philipp Groene, et al.
Published: (2021-03-01) -
ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01)